Abstract
The synthesis and biological profile in vitro of a series of coumarin inhibitors of gyrase B bearing a N-propargyloxycarbamate at C-3' of noviose is presented. Replacement of the 5-methylpyrrole-2-carboxylate of coumarin drugs with an N-propargyloxycarbamate bioisostere leads to analogues with improved antibacterial activity. Analysis of crystal structures of coumarin antibiotics with the 24 kDa N-terminal domain of the gyrase B protein provides a rational for the excellent inhibitory potency of C-3' N-alkoxycarbamates.
MeSH terms
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / pharmacology
-
Carbamates / chemical synthesis*
-
Carbamates / pharmacology
-
Coumarins / chemical synthesis*
-
Coumarins / pharmacology
-
DNA Gyrase
-
DNA, Superhelical / antagonists & inhibitors
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology
-
Escherichia coli / drug effects
-
Microbial Sensitivity Tests
-
Pyrroles / chemistry*
-
Staphylococcus aureus / drug effects
-
Stereoisomerism
-
Topoisomerase II Inhibitors*
Substances
-
Anti-Bacterial Agents
-
Carbamates
-
Coumarins
-
DNA, Superhelical
-
Enzyme Inhibitors
-
Pyrroles
-
Topoisomerase II Inhibitors
-
DNA Gyrase